Drug

Infliximab-dyyb [Inflectra]

Indication

It’s a biosimilar to infliximab [Remicade], so it has the same indications. Primarily, you’re going to see it used for Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. But you’ll also see it occasionaly used for ankylosing spondylitis and psoriasis.

FDA Approval, Clinical, PracticeBrandon DysonApril 12, 2016Inflectra, Infliximab, Biosimilar, Remicade